RGC
Regencell Bioscience Holdings Ltd
4.90$
-3.6%
vs. previous close
Closing price · As of: Nov 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.6% | +2.2% | -1.1% | -100.0% | – | – | – | – | – | – | – | |
| – | +987.8% | +1.6% | -90.0% | – | – | +178.0% | +2,184.5% | +27.3% | -3.1% | -47.3% | +3.0% | |
| – | -33.3% | +2.6% | +54.3% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +69.2% | +13.5% | +473.1% | -37.0% | -32.6% | -11.1% | +37.0% | |
| – | +572.4% | +2.4% | -83.1% | -99.8% | +96.0% | +201.8% | +439.6% | -12.8% | -36.8% | -13.5% | +330.6% | |
| – | +32.4% | +2.9% | -19.4% | -100.0% | +107.8% | +70.0% | +451.5% | -17.6% | -36.4% | -15.4% | +235.2% | |
| – | +10.6% | +1.5% | -21.1% | -100.1% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +41.8% | +11.2% | -24.1% | -100.2% | – | – | – | – | – | – | – | |
| – | +36.4% | +11.1% | -8.6% | -100.0% | – | – | – | – | – | – | – | |
| – | +45.3% | +11.1% | -34.1% | -100.3% | – | – | – | – | – | – | – | |
| – | +20.3% | +8.9% | -8.5% | -100.1% | – | – | – | – | – | – | – |
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.